{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:31:51Z","timestamp":1793691111299,"version":"4.5.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jdermsci.2017.12.016","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T17:42:03Z","timestamp":1514569323000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response"],"prefix":"10.1016","volume":"90","author":[{"given":"Yoshiyuki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2017.12.016_bib0005","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.seminoncol.2017.06.007","article-title":"Nivolumab and pembrolizumab. Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable","volume":"44","author":"Prasad","year":"2017","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-407707-2.00001-1","article-title":"The interdisciplinary science of T-cell recognition","volume":"119","author":"Huppa","year":"2013","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0020","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jso.21202","article-title":"Lymph node assessment in melanoma","volume":"99","author":"Easson","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fsc.2017.03.013","article-title":"Reconstruction of cheek defects secondary to Mohs microsurgery or wide local excision","volume":"25","author":"Hanks","year":"2017","journal-title":"Facial Plast. Surg. Clin. N. Am."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0035","first-page":"212","article-title":"Reverse peroneal artery flap for large heel and sole defects: a reliable coverage","volume":"6","author":"Bhatt","year":"2017","journal-title":"World J. Plast. Surg."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0040","doi-asserted-by":"crossref","first-page":"e1182278","DOI":"10.1080\/2162402X.2016.1182278","article-title":"The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development","volume":"5","author":"Stachura","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fimmu.2014.00560","article-title":"The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice \u2013 implications for cancer therapy","volume":"5","author":"Chaurio","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0050","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.4049\/jimmunol.161.10.5516","article-title":"Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines","volume":"161","author":"Wang","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0055","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/SAP.0b013e318216b61f","article-title":"Achieving an optimal cosmetic result with excision of lesions on the face","volume":"68","author":"Hudson","year":"2012","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0065","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0070","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.14694\/EdBook_AM.2014.34.e397","article-title":"Developments in the treatment of locally advanced and metastatic squamous cell carcinoma of the skin: a rising unmet need","author":"Palyca","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.jdermsci.2017.12.016_bib0075","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117310204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117310204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T08:50:57Z","timestamp":1693385457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181117310204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0923181117310204"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.016","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}